Agenus Inc (NAS:AGEN)
$ 14.56 0.99 (7.3%) Market Cap: 305.75 Mil Enterprise Value: 341.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q3 2021 Agenus Inc Earnings Call Transcript

Nov 09, 2021 / 01:30PM GMT
Release Date Price: $87.34 (+6.46%)
Operator

Good day, and thank you for standing by. Welcome to the Agenus Third Quarter 2021 Financial Results Conference Call. (Operator Instructions)

I would now like to hand the conference over to Divya Vasudevan. Thank you. Please go ahead.

Divya Vasudevan
Agenus Inc. - Senior Director of Oncology Strategy & IR

Thank you, Tamia, and thank you all for joining us today. Todayâs call is being webcast and will be available on our website for replay. Iâd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and time line as well as time lines for data relief and partnership opportunities. These statements are subject to risks and uncertainties, and we refer you to our SEC filings for more details on these risks. As another reminder, this call is being recorded for audio broadcast. Joining me today are Dr. Garo Armen, Chairman and Chief Executive Officer; Dr. Jennifer Buell, Chief Executive Officer of MiNK Therapeutic, Dr. Steven OâDay, Chief Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot